Michael Scolaro

Michael Scolaro

Oct 06, 2017

Group 6 Copy 217
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Synthesis of a Kidney Cancer Drug

We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...

Improving Collaborations for Neglected Tropical Diseases

Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a...

Developing a new treatment for Ebola Virus Disease

Ebola is now a threat of global significance. Fatalities are a consequence of the human body's overreactive...

Backer Badge Funded